Results 121 to 130 of about 1,922,511 (410)
The American College of Medical Genetics and Genomics (ACMG) and the National Coordinating Center for the Regional Genetics Networks (NCC)-developed ACT sheets are a vital resource for state newborn screening (NBS) programs. They allow NBS programs to be
Virginia Sack+4 more
doaj +1 more source
Modelling costs and outcomes of newborn hearing screening: The economic part of a German health technology assessment project [PDF]
The prevalence of newborn hearing disorders is 1-3 per 1000. Crucial for later outcome are correct diagnosis and effective treatment in the first year of life. With BERA and TEOAE low-risk techniques for early detection are available. Universal screening
Grill, Eva+3 more
core
This study fabricates highly sensitive, uniform SERS substrates scalable to wafer level. The dual‐function substrates integrate high‐density hot spots and spectral references for accurate quantitative detection, achieving 10⁻¹2 M BPE sensitivity (<5% deviation). Their application in monitoring urinary caffeine citrate for preterm infant apnea treatment
Yuanhao Jin+7 more
wiley +1 more source
Translating Molecular Technologies into Routine Newborn Screening Practice
As biotechnologies advance and better treatment regimens emerge, there is a trend toward applying more advanced technologies and adding more conditions to the newborn screening (NBS) panel.
Sarah M. Furnier, M. Durkin, M. Baker
semanticscholar +1 more source
This review focuses on the application of synthetic biodegradable microarray patches (MAPs) in sustained drug delivery. Compared to conventional MAPs which release drugs into the skin in an immediate manner, these implantable MAPs release drugs into skin microcirculation gradually as the biodegradable polymers degrade, thus offering sustained release ...
Li Zhao+6 more
wiley +1 more source
In this study, we evaluated the implementation of a second-tier genetic screening test using an amplicon-based next-generation sequencing (NGS) panel in our laboratory during the period of 1 September 2021 to 31 August 2022 for the newborn screening (NBS)
Toby Chun Hei Chan+12 more
doaj +1 more source
Challenges in the management of Phenylketonuria in Malta [PDF]
Phenylketonuria (PKU) is a rare metabolic disorder comprising a number of different enzyme deficiencies. In Malta, dihydropteridine reductase (DHPR) deficiency appears to be more common than phenylalanine hydroxylase deficiency (classical PKU), and is ...
Attard Montalto, Simon, Attard, Stephen
core
Implantable biosensors hold the promise to revolutionize the way disease diagnosis and progression during treatment are viewed. However, in the current state of art, their efficiency is limited by certain material challenges. Porous Silicon (pSi) is a viable material for in vivo monitoring of biomarkers, and its potential as an implantable biosensor is
Pritam Sharma+4 more
wiley +1 more source
Newborn screening for inborn errors of metabolism and endocrinopathies: an update [PDF]
Newborn screening for inborn errors of metabolism and endocrinopathies has expanded during the last two decades, mainly owing to the introduction of new technologies such as tandem mass spectrometry and DNA analysis.
Fingerhut, Ralph, Olgemöller, Bernhard
core
Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics. [PDF]
Inborn errors of metabolism (IEMs) are a group of inherited diseases with variable incidences. IEMs are caused by disrupting enzyme activities in specific metabolic pathways by genetic mutations, either directly or indirectly by cofactor deficiencies ...
Fiehn, Oliver+2 more
core +2 more sources